Notes from March 16th 2007 U.S. Capitol Briefing on Thailand’s Compulsory Licenses

On Friday, March 16, KEI organized a briefing in the U.S. Capitol on Thailand’s recent compulsory licenses on three drugs; two for HIV/AIDS (Merck’s efavirenz (Stocrin) and Abbott’s lopinavir + ritonavir (Kaletra)) and one for heart disease (Sanofi’s clopidogrel (Plavix)). … Continue Reading

March 8, 2007 Geneva Q&A Session on Thai White Paper

Knowledge Ecology International: Q&A Session on Thai White Paper (Facts and Evidences on the 10 Burning Issues Related to the Government Use of Patents on Three Patented Essential Drugs in Thailand) Geneva, Switzerland 8 March 2007 Thiru Balasubramaniam On Thursday,… Continue Reading

U.S. DoS Cable: U.S. PHARMA FIRMS THREATENED WITH LICENSING (Brazil)

R 031944Z JUN 05 – June 3, 2005FROM: American Embassy BrasiliaTO: Secretary of State, Washington, D.C.SUBJECT: AMBASSADOR MEETS WITH U.S. PHARMACEUTICAL FIRMS THREATENED WITH LICENSING 1. (SBU) Summary.  On May 24 and 25, U.S. pharmaceutical companies Gilead Sciences, Abbott Laboratories,… Continue Reading